Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity
Crossref DOI link: https://doi.org/10.1007/s40121-014-0033-y
Published Online: 2014-08-26
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Makari, Doris
Jensen, Kathryn M.
Harris, Brian
Jafri, Hasan S.